Immune Checkpoints: Novel Therapeutic Targets to Attenuate Sepsis-Induced Immunosuppression

Sepsis is a leading cause of death in intensive care units and survivors develop prolonged immunosuppression and a high incidence of recurrent infections. No definitive therapy exists to treat sepsis and physicians rely on supportive care including antibiotics, intravenous fluids, and vasopressors....

Descripción completa

Detalles Bibliográficos
Autores principales: McBride, Margaret A., Patil, Tazeen K., Bohannon, Julia K., Hernandez, Antonio, Sherwood, Edward R., Patil, Naeem K.
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Frontiers Media S.A. 2021
Materias:
Immunology
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7886986/
https://www.ncbi.nlm.nih.gov/pubmed/33613563
http://dx.doi.org/10.3389/fimmu.2020.624272

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7886986/
https://www.ncbi.nlm.nih.gov/pubmed/33613563
http://dx.doi.org/10.3389/fimmu.2020.624272

Ejemplares similares